Sol-Gel Technologies (SLGL) Revenue (2018 - 2025)
Sol-Gel Technologies (SLGL) reported Revenue of $696000.0 for Q4 2025, up 150.36% year-over-year from $278000.0 in Q4 2024, and up 74.0% on a QoQ basis from $400000.0 in Q3 2025.
Sol-Gel Technologies (SLGL) has 8 years of Revenue data on file, last reported at $696000.0 in Q4 2025.
- Quarterly Revenue rose 150.36% year-over-year to $696000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $18.6 million (up 61.78% YoY) and the FY2025 annual result came in at $19.4 million, up 68.04% from the prior year.
- Revenue grew to $696000.0 in Q4 2025 per SLGL's latest filing, from $400000.0 in the prior quarter.
- Across five years, Revenue topped out at $3.0 billion in Q1 2022 and bottomed at $100000.0 in Q4 2022.
- The 5-year median for Revenue is $701000.0 (2021), against an average of $179.9 million.
- Peak annual rise in Revenue reached 427860.06% in 2022, while the deepest fall reached 99.52% in 2022.
- Tracing SLGL's Revenue over 5 years: stood at $20.8 million in 2021, then slumped by 99.52% to $100000.0 in 2022, then soared by 347.0% to $447000.0 in 2023, then slumped by 37.81% to $278000.0 in 2024, then soared by 150.36% to $696000.0 in 2025.
- Per Business Quant, the three latest SLGL Revenue figures stand at $696000.0 (Q4 2025), $400000.0 (Q3 2025), and $17.3 million (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 306.30 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 2.99 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 3.61 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 1.17 Bn |
| 10 | Sol-Gel Technologies | 205.76 Mn | 194.73 Mn | - | 696,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 696,000.00 |
| Sep 30, 2025 | 400,000.00 |
| Jun 30, 2025 | 17.26 Mn |
| Dec 31, 2024 | 278,000.00 |
| Sep 30, 2024 | 5.36 Mn |
| Jun 30, 2024 | 5.43 Mn |
| Dec 31, 2023 | 447,000.00 |
| Sep 30, 2023 | 213,000.00 |
| Jun 30, 2023 | 594,000.00 |
| Dec 31, 2022 | 100,000.00 |
| Sep 30, 2022 | 261,000.00 |
| Jun 30, 2022 | 3.52 Mn |
| Mar 31, 2022 | 3.00 Bn |
| Dec 31, 2021 | 20.81 Mn |
| Sep 30, 2021 | 1.34 Mn |
| Jun 30, 2021 | 928,000.00 |
| Mar 31, 2021 | 701,000.00 |
| Dec 31, 2020 | 2.06 Mn |
| Sep 30, 2020 | 2.12 Mn |
| Jun 30, 2020 | 1.13 Mn |
| Mar 31, 2020 | 3.47 Mn |
| Dec 31, 2019 | 4.02 Mn |
| Sep 30, 2019 | 4.73 Mn |
| Jun 30, 2019 | 7.79 Mn |
| Mar 31, 2019 | 6.36 Mn |
| Dec 31, 2018 | -2,000.00 |
| Sep 30, 2018 | 38,000.00 |
| Jun 30, 2018 | 49,000.00 |
| Mar 31, 2018 | 44,000.00 |